Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India News
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma market’s long standing market leader GlaxoSmithKline’s Augmentin, an antibiotic. During September, Mounjaro recorded sales of Rs 80 crore, becoming the second-largest brand in the pharma retail market, latest data culled by TOI from market research firm Pharmatrac…